Bio-Rad makes life science research tools and clinical diagnostic test systems for labs, hospitals and research institutions. It last closed at $358.25 on Nov 17, down 0.65% on the day. BIO reports earnings on Thu, Feb 11, 2027. In the past 30 days there were 2 dark pool prints totaling $4.5M, the largest $2.5M.
Only 1 firm rated BIO in the past 90 days, not enough for a consensus
Average 12-month target
$440.00
▲ 22.8% upside
Based on 1 analyst who set a price target on BIO in the past 90 days. The average target is $440.00, with a high of $440.00 and a low of $440.00, compared with the last close of $358.25.
Low $440.00Avg $440.00High $440.00
Blue marker: last close $358.25
Highest target$440.00
Average target$440.00
Lowest target$440.00
Latest rating changes
RBC CapitalTarget raised
Nov 5Buy$390 → $440
RBC CapitalTarget raised
Aug 7Buy$370 → $390
CitigroupMaintained
Aug 5Hold$330
RBC CapitalTarget raised
Aug 5Buy$320 → $370
Wells FargoMaintained
Aug 5Hold$330
Date
Firm
Action
Rating
Price target
Nov 5
RBC Capital
Target raised
Buy
$390 → $440
Aug 7
RBC Capital
Target raised
Buy
$370 → $390
Aug 5
Citigroup
Maintained
Hold
$330
Aug 5
RBC Capital
Target raised
Buy
$320 → $370
Aug 5
Wells Fargo
Maintained
Hold
$330
Loading…
Technical Analysis
BIO · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend
The stock is 4% below its 20 day and 4% below its 50 day average. It is 11% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $355.83, and the nearest resistance the Pivot at $358.76.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 3.3%/day
Key levels
$396.2352 week high+10.6%
$373.8420 day average+4.4%
$372.0050 day average+3.8%
$365.00Swing high (Aug 13)+1.9%
$361.18Pivot R1+0.8%
$358.76Pivot+0.1%
$358.25Last close
$355.83Pivot S1−0.7%
$354.89100 day average−0.9%
$353.97Swing low (Oct 8)−1.2%
$317.63200 day average−11.3%
$236.7352 week low−33.9%
Indicators
RSI (14)
41.21
Middle of its range
Neutral
MACD
-0.57
Below its signal line
Bearish
Stochastic
22.4
Middle of its range
Neutral
ADX (14)
15.5
No clear trend
Williams %R
-85.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-120.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−4.4%
Change over 10 sessions
Bearish
ATR (14)
$11.94
Typical daily range, 3.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumNeutral
StretchNormal
VolatilityNormal, 6.7%/day
Key levels
$396.2352 week high+10.6%
$373.8420 day average+4.4%
$372.0050 day average+3.8%
$365.00Swing high (Aug 13)+1.9%
$361.18Pivot R1+0.8%
$358.76Pivot+0.1%
$358.25Last close
$355.83Pivot S1−0.7%
$354.89100 day average−0.9%
$353.97Swing low (Oct 8)−1.2%
$317.63200 day average−11.3%
$236.7352 week low−33.9%
Indicators
RSI (14)
54.38
Middle of its range
Neutral
MACD
16.82
Below its signal line
Bearish
Stochastic
47.3
Middle of its range
Neutral
ADX (14)
29.2
Trending up
Williams %R
-77.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
8.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.0%
Change over 10 sessions
Bearish
ATR (14)
$23.86
Typical daily range, 6.7% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for BIO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BIO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow BIO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How BIO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BIO is in one of them and how their past BIO trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Bio-rad Laboratories
Bio-Rad is a life science and clinical diagnostics company based in Hercules, California. Its life science unit makes instruments, systems, reagents, and consumables used to separate, purify, and measure cells, proteins, and nucleic acids. Its diagnostics unit supplies test systems, software, test kits, and quality controls for the in vitro diagnostics market. Customers include universities, research institutions, pharmaceutical and biotechnology companies, hospital and reference laboratories, and food testing labs.